Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Johnson & Johnson, Q3
Johnson & Johnson’s stock falls despite Q3 sales beat and guidance raise
Johnson & Johnson reported better-than-expected third-quarter sales and raised its full-year revenue guidance.
Johnson & Johnson: Q3 Earnings Snapshot
The average estimate of seven analysts surveyed by Zacks Investment Research was for earnings of $2.22 per share. The world's biggest maker of health care products posted revenue of $22.47 billion in the period,
Johnson & Johnson Q3: Strengthening Cardiovascular Device Portfolio
Johnson & Johnson's Q3 results exceeded expectations, with 26.5% year-over-year growth in the cardiovascular market and a 5.4% adjusted operational revenue growth. Read more here.
Jets owner Woody Johnson is optimistic at 2-4
Jets owner Woody Johnson is optimistic at 2-4: 'We’re going to kick…'
There’s proof in the pudding and words when it comes to Jets owner Woody Johnson. Johnson spoke at the NFL owners’ meetings on Tuesday. That happened shortly after the Jets traded for All-Pro receiver Davante Adams.
Jets' Woody Johnson Talks Davante Adams Trade, Says 'Status Quo' Won't Lead to Wins
New York Jets owner Woody Johnson didn't mince words about the team's desire to win in the wake of Tuesday's deal to acquire Davante Adams from the Las
Woody Johnson: Jets want to bring a lot of change this week
Jets owner Woody Johnson is eager to see his team win, and win this year. Johnson spoke to reporters at the league meeting shortly after news broke that the Jets will be acquiring wide receiver Davante Adams in a trade with the Raiders,
19m
Johnson & Johnson's MedTech Challenges Loom Amid Chinese Market Pressures And Orthopedics Overhaul, Analysts Say
Johnson & Johnson's Q3 2024 results surpassed analyst expectations, reporting $2.42 EPS and $22.47 billion in sales. Updated 2024 guidance reflects performance improvement but includes costs tied to ...
17h
on MSN
Deloitte, Johnson & Johnson execs say people aren’t using their health benefits until they are in crisis
“We should all care about health equity because that is one more person who is going to have a challenge to care for their ...
1h
on MSN
Michigan football DB Will Johnson 'definitely disappointed' with secondary
Michigan football defensive back Will Johnson didn't need to say anything specific, his body language did the talking on ...
15h
Johnson & Johnson: Balancing Growth Potential with Market Challenges and Legal Risks
Johnson & Johnson (JNJ – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst ...
6m
Joey Graziadei's Liver Condition Means 'He Doesn't Really Have to Pee,' DWTS Partner Jenna Johnson Says (Exclusive)
"Dancing with the Stars" partners Joey Graziadei and Jenna Johnson sounded off on the impressive amount of water Joey drinks ...
20h
on MSN
CBS accused of deceptively editing interviews yet again as Speaker Johnson claims interview was ‘selectively’ trimmed
Johnson, 52, posted three clips showing how his “Face The Nation” answers on topics including hurricane relief and election ...
1h
Pirates' Termarr Johnson Stacks Another Hit in AFL
It was a relatively quiet day for Pittsburgh Pirates No. 3 prospect Termarr Johnson in his return to the lineup in the ...
1h
Advance in-person voting set to begin in Johnson County over the weekend
Advance in-person voting is set to begin over the weekend in Johnson County, with a special election for children planned in ...
6h
on MSN
Bears' Jaylon Johnson is NFL's best defender in passer-rating allowed
Bears cornerback Jaylon Johnson has excelled in pass-coverage this year, leading the league in passer-rating allowed.
Newsweek
3h
Dwayne Johnson Teases 'Wild' Christmas Movie With Chris Evans
Dwayne
Johnson
has previewed his "wild" festive blockbuster Red One ahead of its theatrical release next month. Also ...
2h
Johnson & Johnson’s Growth Potential Highlighted by Strong Q3 Earnings and Promising Pipeline
David Risinger, an analyst from Leerink Partners, maintained the Buy rating on Johnson & Johnson (JNJ – Research Report). The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Related topics
Q3
Trump
Medtech
Pittsburgh Pirates
Health technology
Feedback